| Autor: |
Allepuz Losa, C.A., Sanz Velez, J.I., Gil Sanz, M.J., Plaza Mas, L., Rioja Sanz, L.A. |
| Zdroj: |
The Journal of Urology; October 1995, Vol. 154 Issue: 4 p1407-1411, 5p |
| Abstrakt: |
Purpose: Prostate cancer patients were differentiated using seminal vesicle biopsies related to clinical staging, prostate specific antigen (PSA), Gleason scores and PSA density values. Materials and Methods: A total of 75 patients underwent seminal vesicle biopsies. Patients with no seminal vesicle invasion and negative lymphadenectomy results underwent radical prostatectomy. Results: Efficacy of seminal vesicle biopsy was 90.9 percent. Infiltration rates were 69 percent for disease stage T2b or greater, 68 percent for PSA greater than 10 ng./ml., 78 percent for PSA greater than 20 ng./ml. and 73 percent for type 4 and/or 5 Gleason scores. For the prognosis of seminal vesicle invasion, 0.40 was the best PSA density cutoff point. Conclusions: We recommend seminal vesicle biopsy in patients with stage T2b or greater disease, and with a lower clinical stage when the PSA level is 20 ng./ml. or greater and/or the Gleason score is 7 or greater. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
